b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2288676/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288676/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection" /><meta name="citation_authors" content="Wei Li, Yan Liu, Muhammad Mahmood Mukhtar, Rui Gong, Ying Pan, Sahibzada T. Rasool, Yecheng Gao, Lei Kang, Qian Hao, Guiqing Peng, Yanni Chen, Xin Chen, Jianguo Wu, Ying Zhu" /><meta name="citation_date" content="2008" /><meta name="citation_issue" content="4" /><meta name="citation_volume" content="3" /><meta name="citation_doi" content="10.1371/journal.pone.0001985" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2288676/?report=abstract" /><meta name="citation_pmid" content="18414668" /><meta name="DC.Title" content="Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Wei Li" /><meta name="DC.Contributor" content="Yan Liu" /><meta name="DC.Contributor" content="Muhammad Mahmood Mukhtar" /><meta name="DC.Contributor" content="Rui Gong" /><meta name="DC.Contributor" content="Ying Pan" /><meta name="DC.Contributor" content="Sahibzada T. Rasool" /><meta name="DC.Contributor" content="Yecheng Gao" /><meta name="DC.Contributor" content="Lei Kang" /><meta name="DC.Contributor" content="Qian Hao" /><meta name="DC.Contributor" content="Guiqing Peng" /><meta name="DC.Contributor" content="Yanni Chen" /><meta name="DC.Contributor" content="Xin Chen" /><meta name="DC.Contributor" content="Jianguo Wu" /><meta name="DC.Contributor" content="Ying Zhu" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1371/journal.pone.0001985" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection" /><meta property="og:type" content="article" /><meta property="og:description" content="Interleukin (IL)-32 is a recently described pro-inflammatory cytokine that has been reported to be induced by bacteria treatment in culture cells. Little is known about IL-32 production by exogenous pathogens infection in human individuals.In this study, ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288676/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2288676/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2288676/pdf/pone.0001985.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BDCB5E99A96810000000005AC05AC.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/162310/">v.3(4); 2008</a></li><li class="accid">PMC2288676</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0001985" ref="reftype=publisher&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2008; 3(4): e1985. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Apr 16. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pone.0001985" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0001985</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2288676</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18414668">18414668</a></div></div></div></div><h1 class="content-title">Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Li%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321470176256" co-class="co-affbox">Wei Li</a>,<sup></sup> <a href="/pubmed/?term=Liu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321474756448" co-class="co-affbox">Yan Liu</a>,<sup></sup> <a href="/pubmed/?term=Mukhtar%20MM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321470173888" co-class="co-affbox">Muhammad Mahmood Mukhtar</a>,<sup></sup> <a href="/pubmed/?term=Gong%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321538055296" co-class="co-affbox">Rui Gong</a>,<sup></sup> <a href="/pubmed/?term=Pan%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321538053888" co-class="co-affbox">Ying Pan</a>,<sup></sup> <a href="/pubmed/?term=Rasool%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321571509040" co-class="co-affbox">Sahibzada T. Rasool</a>,<sup></sup> <a href="/pubmed/?term=Gao%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321571507184" co-class="co-affbox">Yecheng Gao</a>,<sup></sup> <a href="/pubmed/?term=Kang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321497043408" co-class="co-affbox">Lei Kang</a>,<sup></sup> <a href="/pubmed/?term=Hao%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321497041552" co-class="co-affbox">Qian Hao</a>,<sup></sup> <a href="/pubmed/?term=Peng%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321501450848" co-class="co-affbox">Guiqing Peng</a>,<sup></sup> <a href="/pubmed/?term=Chen%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321501448992" co-class="co-affbox">Yanni Chen</a>,<sup></sup> <a href="/pubmed/?term=Chen%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321501447136" co-class="co-affbox">Xin Chen</a>,<sup></sup> <a href="/pubmed/?term=Wu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321536685776" co-class="co-affbox">Jianguo Wu</a>,<sup></sup><sup>\n&#x0002a;\n</sup> and  <a href="/pubmed/?term=Zhu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668" class="affpopup" co-rid="_co_idm140321470033312" co-class="co-affbox">Ying Zhu</a><sup></sup><sup>\n&#x0002a;\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140321470176256"><h3 class="no_margin">Wei Li</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Li%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Wei Li</a></div></div><div id="_co_idm140321474756448"><h3 class="no_margin">Yan Liu</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Liu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Yan Liu</a></div></div><div id="_co_idm140321470173888"><h3 class="no_margin">Muhammad Mahmood Mukhtar</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Mukhtar%20MM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Muhammad Mahmood Mukhtar</a></div></div><div id="_co_idm140321538055296"><h3 class="no_margin">Rui Gong</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Gong%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Rui Gong</a></div></div><div id="_co_idm140321538053888"><h3 class="no_margin">Ying Pan</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Pan%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Ying Pan</a></div></div><div id="_co_idm140321571509040"><h3 class="no_margin">Sahibzada T. Rasool</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Rasool%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Sahibzada T. Rasool</a></div></div><div id="_co_idm140321571507184"><h3 class="no_margin">Yecheng Gao</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Gao%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Yecheng Gao</a></div></div><div id="_co_idm140321497043408"><h3 class="no_margin">Lei Kang</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Kang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Lei Kang</a></div></div><div id="_co_idm140321497041552"><h3 class="no_margin">Qian Hao</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Hao%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Qian Hao</a></div></div><div id="_co_idm140321501450848"><h3 class="no_margin">Guiqing Peng</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Peng%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Guiqing Peng</a></div></div><div id="_co_idm140321501448992"><h3 class="no_margin">Yanni Chen</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Chen%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Yanni Chen</a></div></div><div id="_co_idm140321501447136"><h3 class="no_margin">Xin Chen</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Chen%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Xin Chen</a></div></div><div id="_co_idm140321536685776"><h3 class="no_margin">Jianguo Wu</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Wu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Jianguo Wu</a></div></div><div id="_co_idm140321470033312"><h3 class="no_margin">Ying Zhu</h3><p>  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </p><div>Find articles by <a href="/pubmed/?term=Zhu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18414668">Ying Zhu</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Robin Charles May, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140321476553312_ai idm140321470176384_ai idm140321504114768_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140321476553312_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140321476553312_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140321476553312_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People\'s Republic of China,   </div><div class="fm-affl" lang="en" id="edit1">University of Birmingham, United Kingdom</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="nc.ude.uhw@uhzgniy" class="oemail">nc.ude.uhw@uhzgniy</a> (YZ); <a href="mailto:dev@null" data-email="moc.anis.piv@8899uw" class="oemail">moc.anis.piv@8899uw</a> (JW)</div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: YZ WL JW. Performed the experiments: WL YL SR YG GP YC. Analyzed the data: WL YL JW. Contributed reagents/materials/analysis tools: MM RG YP SR LK QH XC. Wrote the paper: YZ WL.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140321476553312_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Jan 18; Accepted 2008 Feb 28.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140321476553312_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Li et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2288676/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140321500184176" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321500184176title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">Interleukin (IL)-32 is a recently described pro-inflammatory cytokine that has been reported to be induced by bacteria treatment in culture cells. Little is known about IL-32 production by exogenous pathogens infection in human individuals.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods and Findings</h3><p id="__p3" class="p p-first-last">In this study, we found that IL-32 level was increased by 58.2&#x00025; in the serum samples from a cohort of 108 patients infected by influenza A virus comparing to that of 115 healthy individuals. Another pro-inflammatory factor cyclooxygenase (COX)-2-associated prostaglandin E2 was also upregulated by 2.7-fold. Expression of IL-32 in influenza A virus infected A549 human lung epithelial cells was blocked by either selective COX-2 inhibitor NS398 or Aspirin, a known anti-inflammatory drug, indicating IL-32 was induced through COX-2 in the inflammatory cascade. Interestingly, we found that COX-2-associate PGE<sub>2</sub> production activated by influenza virus infection was significantly suppressed by over-expression of IL-32 but increased by IL-32-specific siRNA, suggesting there was a feedback mechanism between IL-32 and COX-2.</p></div><div id="__sec3" class="sec sec-last"><h3 id="__sec3title">Conclusions</h3><p id="__p4" class="p p-first-last">IL-32 is induced by influenza A virus infection via COX-2 in the inflammatory cascade. Our results provide that IL-32 is a potential target for anti-inflammatory medicine screening.</p></div></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p5" class="p p-first">Influenza A virus (IV) is a highly contagious single-stranded RNA virus that infects both the upper and lower respiratory tracts of humans. The host innate immune Toll-like receptor 3 (TLR3) was shown previously in cells of myeloid origin to recognize the viral replicative, intermediate double-stranded RNA (dsRNA). Thus, dsRNA is critical for the outcome of the infection and appears to be an active component of viral infection that stimulates antiviral activities. It accumulates during the replication of many viruses <a href="#pone.0001985-Heitmeier1" rid="pone.0001985-Heitmeier1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877965">[1]</a>, <a href="#pone.0001985-Jacobs1" rid="pone.0001985-Jacobs1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878004">[2]</a>, including influenza virus. Prominent sources of dsRNA include viral RNAs containing double-stranded secondary structure and dsRNA formed during viral replication <a href="#pone.0001985-Jacobs1" rid="pone.0001985-Jacobs1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878002">[2]</a>. Furthermore, TLR3 contributes directly to the immune response of respiratory epithelial cells to influenza A virus and dsRNA <a href="#pone.0001985-Guillot1" rid="pone.0001985-Guillot1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877967">[3]</a>, <a href="#pone.0001985-Ciencewicki1" rid="pone.0001985-Ciencewicki1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877997">[4]</a>. Therefore dsRNA treatment was always used to mimic the viral infection in cell lines <a href="#pone.0001985-Steer1" rid="pone.0001985-Steer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877996">[5]</a>, <a href="#pone.0001985-Steer2" rid="pone.0001985-Steer2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877994">[6]</a>, <a href="#pone.0001985-Traynor1" rid="pone.0001985-Traynor1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878007">[7]</a>. In macrophages, dsRNA and viral infection stimulate the expression of pro-inflammatory cytokines such as IL-1alpha, IL-1beta, tumor necrosis factor, and IL-6 <a href="#pone.0001985-Heitmeier1" rid="pone.0001985-Heitmeier1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877995">[1]</a>, <a href="#pone.0001985-Eliopoulos1" rid="pone.0001985-Eliopoulos1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877970">[8]</a>, <a href="#pone.0001985-Maggi1" rid="pone.0001985-Maggi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877985">[9]</a>, <a href="#pone.0001985-Nath1" rid="pone.0001985-Nath1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878005">[10]</a>.</p><p id="__p6">Cyclooxygenase (COX) is the rate-limiting enzyme in the biosynthetic pathway of prostaglandins and thromboxanes. Prostaglandins play an important role in many biological processes. Altered prostanoid production is associated with a variety of illnesses, including acute and chronic inflammation, cardiovascular disease and colon cancer <a href="#pone.0001985-Hinz1" rid="pone.0001985-Hinz1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878015">[11]</a>. Two isoforms of COX were described: COX-1 and COX-2. COX-1 is constitutively expressed in almost all tissues <a href="#pone.0001985-Marnett1" rid="pone.0001985-Marnett1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877982">[12]</a>; COX-2 is the inducible form of the enzyme, which is expressed in response to inflammatory stimuli and growth factors and is involved in mediating pain and inflammatory processes <a href="#pone.0001985-Deng1" rid="pone.0001985-Deng1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877989">[13]</a>, <a href="#pone.0001985-Iniguez1" rid="pone.0001985-Iniguez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877976">[14]</a>. In our previous studies, we identified two viral proteins, the nucleoprotein and spike protein of SARS-CoV, which were involved in up-regulating COX-2 <a href="#pone.0001985-Liu1" rid="pone.0001985-Liu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878014">[15]</a>, <a href="#pone.0001985-Yan1" rid="pone.0001985-Yan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_847062806">[16]</a>. Prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) is synthesized from PGH<sub>2</sub> in a variety of cells, which itself is synthesized from arachidonic acid by the enzyme prostaglandin synthetase COX-2. Its levels can be measured to access the COX-2 activity as described in reference <a href="#pone.0001985-Steer1" rid="pone.0001985-Steer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878010">[5]</a>, <a href="#pone.0001985-Steer2" rid="pone.0001985-Steer2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877991">[6]</a>, <a href="#pone.0001985-Carey1" rid="pone.0001985-Carey1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877983">[17]</a>, <a href="#pone.0001985-Gilroy1" rid="pone.0001985-Gilroy1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878008">[18]</a>.</p><p id="__p7">Interleukin-32 (IL-32), previously called natural killer cell transcript 4, has been recognized as a pro-inflammatory cytokine recently. It is mainly expressed in natural killer cells, T cells, epithelial cells and blood monocytes. IL-32 can induce the pro-inflammatory cytokines TNF-&#x003b1; and IL-1&#x003b2; in murine peritoneal macrophages as well as in phorbol ester-differentiated human THP-1 cells <a href="#pone.0001985-Kim1" rid="pone.0001985-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878013">[19]</a>. It plays an important role in innate and adaptive immune responses, synergism between IL-32 and other well-characterized players in innate immunity has recently been documented <a href="#pone.0001985-Kundu1" rid="pone.0001985-Kundu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877988">[20]</a>. Furthermore, IL-32 contributes to the synovitis during rheumatoid arthritis <a href="#pone.0001985-Joosten1" rid="pone.0001985-Joosten1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877971">[21]</a>. It is stimulated by <em>Mycobacterium tuberculosis</em>\n<a href="#pone.0001985-Netea1" rid="pone.0001985-Netea1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877975">[22]</a> and it synergizes with NOD1 and NOD2 ligands to stimulate IL-1&#x003b2; and IL-6 release in a caspase-1-dependent manner <a href="#pone.0001985-Netea2" rid="pone.0001985-Netea2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877993">[23]</a>. Recently Proteinase 3 has been identified as a specific IL-32&#x003b1; binding protein which cleaves the cytokine to enhance its activity <a href="#pone.0001985-Novick1" rid="pone.0001985-Novick1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877974">[24]</a>.</p><p id="__p8">A number of investigations demonstrated that viral infections stimulate COX-2 expression, followed by PGE<sub>2</sub> accumulation <a href="#pone.0001985-Steer2" rid="pone.0001985-Steer2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878012">[6]</a>, <a href="#pone.0001985-Liu1" rid="pone.0001985-Liu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877969">[15]</a>, <a href="#pone.0001985-Yan1" rid="pone.0001985-Yan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_847062805">[16]</a>, <a href="#pone.0001985-LaraPezzi1" rid="pone.0001985-LaraPezzi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877978">[25]</a>, <a href="#pone.0001985-Mizumura1" rid="pone.0001985-Mizumura1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877980">[26]</a>. However, the role of influenza A virus infection in the regulation of the newly described pro-inflammatory factor IL-32 expression is still unclear. Furthermore, since COX-2 and IL-32 are obligatory mediators of inflammation, the question arises as to whether there is an interaction between the two proteins or they act as independent effectors of host inflammatory response to viral infection.</p><p id="__p9" class="p p-last">Because COX-2 and IL-32 gene expression are associated with inflammatory processes, the aim of this study is to investigate the role of influenza A virus infection in the regulation of IL-32 expression and to determine the molecular mechanisms responsible. Our results showed that influenza A virus infection or poly(IC) treatment activates COX-2 and IL-32 expression by a heretofore unrecognized mechanism, in which influenza A virus stimulates IL-32 expression through COX-2, and IL-32 feedback inhibits COX-2 expression.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Patients</h3><p id="__p10" class="p p-first-last">The study examined 108 consecutive adults with influenza A virus infection (59 male, 49 female, aged 39.2&#x000b1;13.5 yr) seropositive for influenza A antigen and 115 healthy adults (62 male, 53 female, aged 37.6&#x000b1;11.3 yr) seronegative for influenza A antigen. All adults were seronegative for markers of hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis Delta virus, and HIV. All of the investigated serum samples were obtained with the help from Hubei provincial Center for Disease Control and Prevention (Hubei CDC). Informed consent was obtained from each of the patients. The collection of blood samples for research was approved by the Institutional Review Board of the College of Life Sciences, Wuhan University in accordance with guidelines for the protection of human subjects.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">Virus</h3><p id="__p11" class="p p-first-last">The influenza virus strain A/chicken/Hubei/327/2004 (H5N1) used in this study was provided by China Center for Type Culture Collection (CCTCC). Stock virus was propagated in 10-day-old embryonated chicken eggs for 36 to 48 h at 37&#x000b0;C. The allantoic fluid was then harvested, and aliquots were stored at &#x02013;80&#x000b0;C before being used. The final concentration of H5N1 virus infection used in this study was 1 multiplicity of infection (MOI).</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">Plasmids, antibodies, and inhibitors</h3><p id="__p12" class="p p-first">pcDNA3.1-COX-2 was a gift from Dr. Kenneth K. Wu (University of Texas-Houston Medical School, Houston, Texas, USA). Luciferase reporter vector (pGL3) containing a COX-2 promoter region (&#x02212;891/&#x0002b;9) was constructed previously <a href="#pone.0001985-Zhu1" rid="pone.0001985-Zhu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878016">[27]</a>. IL-32 promoter (&#x02212;746/&#x0002b;25) was amplified from human genomic DNA by PCR, using the following primers: <em class="gene">5&#x02032;-GTTACGCGTCCTATTTCAATATGACTGGT-3&#x02032;</em> (sense), <em class="gene">5&#x02032;- GTTAAGCTTAGGGAAAGTCCAGACTCGGG -3&#x02032;</em> (antisense); and then inserted into pGL3-Basic vector to generate IL-32 promoter and Luciferase gene fusion plasmid (pIL-32-Luc). An IL-32 construct was created by RT-PCR amplification of the open reading frame from A549 human lung epithelial cells. To create IL-32-encoding vector, the IL-32 beta gene was amplified using the following primers: <em class="gene">5&#x02032;- CATGAATTCCATGTGCTTCCCGAAGG -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- CTACTCGAGGTATCTTCATTTTGAGGATTG -3&#x02032;</em> (antisense); in which <em>Eco</em>RI and <em>Xho</em>I sites were introduced, respectively. The PCR product was cloned into <em>Eco</em>RI and <em>Xho</em>I sites of pCMV-tag2A (Stratagene) to generate plasmid Flag2A-IL-32, in which IL-32 beta protein was tagged by FLAG.</p><p id="__p13">All of the ten genes of influenza A virus H5N1 were obtained by RT-PCR from H5N1 infected A549 cells and constructed into pCMV-Flag2A vector to generate IV-gene expressing plasmids (Flag2A-HA, Flag2A-NA, Flag2A-NP, Flag2A-NS1 Flag2A-NS2, Flag2A-M1, Flag2A-M2, Flag2A-PA, Flag2A-PB1, Flag2A-PB2) using specific pairs of primers for each influenza A virus gene as follows: HA: <em class="gene">5&#x02032;- ACGGGATCCGATGGAGAAAATAGTGCTT -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- ACGCTCGAGTGAACTCACAAATTTA -3&#x02032;</em> (antisense); NA: 5&#x02032;-GCGGAATTCTATGAATCCAAATCAGAAGATAATAAC-3&#x02032; (sense), <em class="gene">5&#x02032;- AAAGGGCCCCTACTTGTCAATGGTGAATGG -3&#x02032;</em> (antisense); NP: <em class="gene">5&#x02032;- AAAGGATCCCATGGCGTCTCAAGGCACC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- ACCGAATTCTTAATTGTCATACTCC -3&#x02032;</em> (antisense); NS1: <em class="gene">5&#x02032;- ACAGGATCCGATGGATTCCAACACTGTGTC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- CTTGAATTCTCAGCCACCTTATTTC -3&#x02032;</em> (antisense); NS2: <em class="gene">5&#x02032;- ACAGGATCCGATGGATTCCAACACTGTGTC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- CTAGGGCCCATCATTAAATAAGCTGAAACGA -3&#x02032;</em> (antisense); M1: <em class="gene">5&#x02032;- TCTGAATTCGATGAGTCTTCTAAC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- TTAGGGCCCGCAACAACAAGAGGATCACT -3&#x02032;</em> (antisense); M2: <em class="gene">5&#x02032;- TCTGAATTCGATGAGTCTTCTAAC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- TTTCTCGAGGGTAGTTTTTTACTCCAAT -3&#x02032;</em> (antisense); PA: <em class="gene">5&#x02032;- AATGGATCCTATGGAAGACTTTGTGCGAC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- CAGGGGCCCTACTTCAGTGCATGTGCGAG -3&#x02032;</em> (antisense); PB1: <em class="gene">5&#x02032;- CAAACGGATCCCATGGATGTCAATCCGAC -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- CAAGAAGCTTTCACTATTTCTGCCGTCTG -3&#x02032;</em> (antisense); PB2; <em class="gene">5&#x02032;- GCAAAAGCAGGTCAAATATA -3&#x02032;</em> (sense), <em class="gene">5&#x02032;- GTTTTTAAACAATTCGACACTA -3&#x02032;</em> (antisense); IL-32 siRNA plasmid was constructed by ligating the corresponding pairs of oligonucleotide to p<em>Silencer&#x02122;</em> 2.1-U6 neo (Ambion, Inc., Augstin, TX, USA) based on the sequences described previously <a href="#pone.0001985-Shoda1" rid="pone.0001985-Shoda1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878011">[28]</a>. All constructs was confirmed by DNA sequencing.</p><p id="__p14">Monoclonal mouse antibody against human COX-2 was purchased from Cayman Chemical Company (Ann Arbor, MI, USA). Polyclonal goat antibody against human IL-32 was purchased from R&#x00026;D Systems, Inc. USA. Polyclonal goat antibody specific for human &#x003b2;-actin (SC-1616) were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA).</p><p id="__p15" class="p p-last">N-(2-cyclohexylosy-4-nitrophenyl)-methanesulphonamide (NS398) (Promega, Madison, WI) was dissolved in DMSO and used as indicated concentrations according to reference <a href="#pone.0001985-Copeland1" rid="pone.0001985-Copeland1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878009">[29]</a>. Aspirin (Sigma, St. Louis, MO, USA), Synthetic polyinosinic-polycytidylic acid poly(IC) (Sigma, St. Louis, MO, USA), and recombinant human interferon-&#x003b3; (IFN-&#x003b3;) (Peprotech, London, UK) were dissolved in PBS and used at a final concentration of 5 mM, 50 &#x000b5;g/ml, 150 U/ml, respectively.</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">Cell culture</h3><p id="__p16" class="p p-first-last">HEK 293T cells were cultured in DMEM (GibcoBRL, USA), human lung epithelial cells A549 were cultured in F12K media (GibcoBRL, USA), respectively. All media were supplemented with 10&#x00025; fetal calf serum, 100 U/ml penicillin and 100 &#x000b5;g/ml streptomycin sulfate and all cell cultures were maintained at 37&#x000b0;C in a 5&#x00025; CO<sub>2</sub> incubator.</p></div><div id="s2e" class="sec"><h3 id="s2etitle">Transient transfection and Luciferase reporter gene assays</h3><p id="__p17" class="p p-first-last">Cells were plated at density of 4.0&#x000d7;10<sup>5</sup> cells per 24-well plate or 6-well plate and grown to confluence reaching about 80&#x00025; at the time of transfection. The plasmids which express COX-2, IL-32, the pGL3-promoter plasmids, pRL-TK (Promega) were co-transfected into the cells by using Lipofectamine 2000 reagent (Invitrogen). If necessary, poly(IC), IFN-&#x003b3;, NS398, and Aspirin were added into the culture media after transfection. 24 h post-transfection, cells were serum-starved for another 24 h before being harvested. Luciferase activities were measured 48 h after transfection according to the manufacturer\'s instructions (Promega) and Renilla Luciferase activities were determined as internal control for transfection efficiency as previously described <a href="#pone.0001985-Liu1" rid="pone.0001985-Liu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878003">[15]</a>. Assays were performed in triplicate and expressed as means&#x000b1;s.d. relative to vector or mock control as 100 (RLU) or luciferase activity (LUC).</p></div><div id="s2f" class="sec"><h3 id="s2ftitle">Semiquantitative RT-PCR analysis</h3><p id="__p18" class="p p-first-last">Total RNA, isolated from A549 cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA), was treated with DNase I and reverse-transcribed with MLV reverse transcriptase (Promega) and random primers (Takara). PCR was performed in 25 &#x000b5;l reactions with the detection primer pairs described as follows: IL-32 sense: <em class="gene">5&#x02032;- CATGAATTCCATGTGCTTCCCGAAGG-3&#x02032;</em>; IL-32 antisense: <em class="gene">5&#x02032;- CTACTCGAGGTATCTTCATTTTGAGGATTG -3&#x02032;</em>. Detection primers for COX-2, and &#x003b2;-actin were described previously <a href="#pone.0001985-Liu1" rid="pone.0001985-Liu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878000">[15]</a>. &#x003b2;-actin was amplified by PCR for normalization in all reactions. The primers for IL-32 were designed for detecting all known isoforms of human IL-32. PCR products were analyzed by electrophoresis on 1&#x00025; agarose gel containing ethidium bromide.</p></div><div id="s2g" class="sec"><h3 id="s2gtitle">Western blot analysis</h3><p id="__p19" class="p p-first-last">Protein extracts of cultured cells were prepared by suspending cells in lysis buffer (0.01&#x00025; EDTA, 0.1&#x00025; Triton X-100, 10&#x00025; proteinase inhibitors cocktail), sonication, and centrifugation. Concentrations of proteins in supernatant were quantified using protein assay kit (Bio-Rad). Western blot analysis was performed using COX-2 and IL-32 antibodies and sample loading was normalized by using &#x003b2;-actin antibody. Immunoblots were visualized with the ECL detection system (Pierce, Rockford, IL, USA).</p></div><div id="s2h" class="sec"><h3 id="s2htitle">COX-2 activity</h3><p id="__p20" class="p p-first-last">Because increased PGE<sub>2</sub> is the metabolite of COX-2 enzyme catalysis in epithelial cells, COX-2-derived PGE<sub>2</sub> levels in the culture medium was assayed by the Biotrak Prostaglandin E2 Enzyme Immunoassay system (R &#x00026; D Systems) according to the manufacturer\'s protocol.</p></div><div id="s2i" class="sec"><h3 id="s2ititle">ELISA for IL-32 measurement</h3><p id="__p21" class="p p-first-last">ELISA assays were developed using IL-32 antibody and a polypeptide, H-KEELTPQKCSEPQSSK-OH, (GL Biochem Ltd. Shanghai China) was synthesized as an antigen for making an IL-32 protein standard curve. ELISAs were prepared by coating the bottom of a 96-well plate with diluted serum samples or culture media. 50 &#x000b5;l of 2 &#x000b5;g/ml capture antibody was incubated for one hour then washed three times with TBST, followed by HRP-labeled secondary antibody incubation for 15 minutes, and finally washed six times with TBST. ELISAs were developed with TMB (Sigma) substrate and the absorbance at double-wavelength 450 nm/630 nm was measured. IL-32 concentrations were calculated from the standard curve.</p></div><div id="s2j" class="sec sec-last"><h3 id="s2jtitle">Statistical analysis</h3><p id="__p22" class="p p-first-last">All experiments were reproducible and were carried out in triplicate or quadruplicate. Each set of experiments was repeated at least three times with similar results, and a representative one is shown. The results are presented at the means&#x000b1;s.d. Student\'s <em>t</em> test for paired samples was used to determine statistical significance. Differences were considered statistically significant at a value of <em>P</em>&#x02264;0.05.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">Serum levels of PGE<sub>2</sub> and IL-32</h3><p id="__p23" class="p p-first">The serum levels of PGE<sub>2</sub> and IL-32 were significantly higher in the cohort of patients with influenza A virus infection investigated in comparison with healthy control individuals (mean&#x000b1;SEM for PGE<sub>2</sub>, 808.7&#x000b1;52.9 vs. 299.5&#x000b1;45.4 pg/ml; for IL-32, 183.8&#x000b1;43.6 vs. 116.2&#x000b1;29.3 pg/ml, respectively, <em>P</em>&#x0003c;0.01 Mann Whitney-U) as described in <a href="/pmc/articles/PMC2288676/table/pone-0001985-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0001985-t001" rid-ob="ob-pone-0001985-t001" co-legend-rid=""><span>Table 1</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0001985-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Demographic and baseline characteristics, serum levels of PGE<sub>2</sub> and IL-32 from influenza A positive patients and healthy individuals.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321502496128" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Characteristic</td><td align="left" rowspan="1" colspan="1">Healthy Individuals (N&#x0200a;=&#x0200a;115)</td><td align="left" rowspan="1" colspan="1">Patients (N&#x0200a;=&#x0200a;108)</td><td align="left" rowspan="1" colspan="1">P Value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age-yr</td><td align="left" rowspan="1" colspan="1">37.6&#x000b1;11.3</td><td align="left" rowspan="1" colspan="1">39.2&#x000b1;13.5</td><td align="left" rowspan="1" colspan="1">0.85</td></tr><tr><td align="left" rowspan="1" colspan="1">Male sex-no.(&#x00025;)</td><td align="left" rowspan="1" colspan="1">62 (54)</td><td align="left" rowspan="1" colspan="1">59 (55)</td><td align="left" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" rowspan="1" colspan="1">Race or ethnic group-no.(&#x00025;) Asian</td><td align="left" rowspan="1" colspan="1">115 (100)</td><td align="left" rowspan="1" colspan="1">108 (100)</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Time-no.(&#x00025;)</td><td align="left" rowspan="1" colspan="1">115 (100)</td><td align="left" rowspan="1" colspan="1">108 (100)</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Oct.8th/2007-Oct.19th/2007</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Region-no.(&#x00025;)</td><td align="left" rowspan="1" colspan="1">115 (100)</td><td align="left" rowspan="1" colspan="1">108 (100)</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Hubei province, China</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">HA-Antigen-positive-no.(&#x00025;)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">108 (100)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-HA-positive-no.(&#x00025;)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">108 (100)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Viral genotype A (H3/H1)-no.</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">108 (85/23)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">PGE2-pg/ml</td><td align="left" rowspan="1" colspan="1">299.5&#x000b1;45.4</td><td align="left" rowspan="1" colspan="1">808.7&#x000b1;52.9</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-32-pg/ml</td><td align="left" rowspan="1" colspan="1">116.2&#x000b1;29.3</td><td align="left" rowspan="1" colspan="1">183.8&#x000b1;43.6</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></div><div id="largeobj_idm140321502496128" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/table/pone-0001985-t001/?report=objectonly">Open in a separate window</a></div></div></div><div id="s3b" class="sec"><h3 id="s3btitle">COX-2 and IL-32 activation in response to influenza A virus infection and dsRNA treatment in a time-dependent manner</h3><p id="__p24" class="p p-first">It has been reported that influenza virus can activate the expression of COX-2 in cell culture systems <a href="#pone.0001985-Mizumura1" rid="pone.0001985-Mizumura1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878006">[26]</a> and that dsRNA can induce the production of COX-2, followed by PGE<sub>2</sub> release <a href="#pone.0001985-Steer1" rid="pone.0001985-Steer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877973">[5]</a>. Initially, we investigated whether influenza A virus infection and dsRNA plays a role, if any, in the regulation of IL-32 expression. A549 cells were infected with influenza A virus or treated with poly(IC)&#x0002b;IFN-&#x003b3;, results showed that A549 cells were susceptible to influenza virus infection and apparent cytopathic effect was observed after viral infection. The culture supernatants and cell lysates were harvested at different time points after infection or induction as follows: 0 h, 6 h, 12 h, 24 h, 48 h. PGE<sub>2</sub> accumulation (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g001" rid-ob="ob-pone-0001985-g001" co-legend-rid="lgnd_pone-0001985-g001"><span>Fig. 1A</span></a>) and IL-32 production (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g001" rid-ob="ob-pone-0001985-g001" co-legend-rid="lgnd_pone-0001985-g001"><span>Fig. 1B</span></a>) in culture supernatants were measured as described in <a href="#s2" rid="s2" class=" sec">materials and methods</a> section. COX-2, IL-32 mRNA (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g001" rid-ob="ob-pone-0001985-g001" co-legend-rid="lgnd_pone-0001985-g001"><span>Fig. 1C</span></a>) and protein (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g001" rid-ob="ob-pone-0001985-g001" co-legend-rid="lgnd_pone-0001985-g001"><span>Fig. 1D</span></a>) expression levels in lysated cells were examined by semiquantitative RT-PCR and western blot analyses, respectively. These results suggested that both influenza A virus infection and dsRNA treatment could activate the expression of COX-2 and IL-32 in A549 cells in a time-dependent manner.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001985-g001" co-legend-rid="lgnd_pone-0001985-g001"><a href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/" target="figure" rid-figpopup="pone-0001985-g001" rid-ob="ob-pone-0001985-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321473428848" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2288676_pone.0001985.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001985.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2288676/bin/pone.0001985.g001.jpg" /></a></div><div id="largeobj_idm140321473428848" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001985-g001"><div><a class="figpopup" href="/pmc/articles/PMC2288676/figure/pone-0001985-g001/" target="figure" rid-figpopup="pone-0001985-g001" rid-ob="ob-pone-0001985-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>COX-2 and IL-32 were induced in A549 human lung epithelial cells in response to influenza A virus infection or dsRNA treatment in a time-dependent manner.</strong><p id="__p25">Time-dependent of PGE<sub>2</sub> (A) and IL-32 (B) accumulations in A549 culture supernatants are shown in response to influenza A virus infection (1 MOI) or poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) treatment. Data are expressed as mean&#x000b1;s.d. of three independent experiments. Time-dependent of COX-2 and IL-32 mRNA accumulations (C) in cell lysates are shown by Semiquantitative RT-PCR analysis and protein productions (D) shown by western blot analysis, in which A549 cells were harvested at indicated time points after influenza A virus infection (1 MOI) or 48 h treatment with poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml). The gel or blot is a representative of three experiments with similar results.</p></div></div></div></div><div id="s3c" class="sec"><h3 id="s3ctitle">Identification of the viral components involved in influenza A virus-stimulated COX-2 and IL-32 expression</h3><p id="__p26" class="p p-first">To identify the viral components which play important roles in IV-stimulated pro-inflammatory factors COX-2 and IL-32 expression, we screened all ten proteins of influenza virus: HA, NA, NP, NS1, NS2, M1, M2, PA, PB1, PB2 and poly(IC) (to mimic viral replicative intermediate dsRNA) by luciferase assays. Results showed that poly(IC), poly(IC)&#x0002b;IFN-&#x003b3;, and NS1 are the most important factors in the induction of either COX-2 (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g002" rid-ob="ob-pone-0001985-g002" co-legend-rid="lgnd_pone-0001985-g002"><span>Fig. 2A</span></a>) or IL-32 (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g002" rid-ob="ob-pone-0001985-g002" co-legend-rid="lgnd_pone-0001985-g002"><span>Fig. 2B</span></a>) promoter activities, which means dsRNA and NS1 are the key viral components involved in IV-triggered COX-2 and IL-32 expression during viral infection. In this study, we focused on the function of dsRNA in inflammatory response to IV infection.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001985-g002" co-legend-rid="lgnd_pone-0001985-g002"><a href="/pmc/articles/PMC2288676/figure/pone-0001985-g002/" target="figure" rid-figpopup="pone-0001985-g002" rid-ob="ob-pone-0001985-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321469788464" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2288676_pone.0001985.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001985.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2288676/bin/pone.0001985.g002.jpg" /></a></div><div id="largeobj_idm140321469788464" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/figure/pone-0001985-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001985-g002"><div><a class="figpopup" href="/pmc/articles/PMC2288676/figure/pone-0001985-g002/" target="figure" rid-figpopup="pone-0001985-g002" rid-ob="ob-pone-0001985-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Screening of viral proteins or viral replicative intermediate dsRNA involved in induction of COX-2/ IL-32.</strong><p id="__p27">Reporter plasmids pCOX-2-Luc (A), pIL-32-Luc (B), and pRL-TK were cotransfected along with all 10 viral gene constructs (Flag2A-HA, Flag2A-NA, Flag2A-NP, Flag2A-NS1, Flag2A-NS2, Flag2A-M1, Flag2A-M2, Flag2A-PA, Flag2A-PB1, Flag2A-PB2) and control vectors (Flag2A) or treated with or without poly(IC) (50 &#x000b5;g/ml), poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) into A549 cells which are indicated on the horizontal axis respectively. Luciferase activity was measured as described in <a href="#s2" rid="s2" class=" sec">methods</a> section. Results are expressed as the mean&#x000b1;s.d. of three independent experiments performed in triplicate and normalized by Renilla activities.</p></div></div></div></div><div id="s3d" class="sec"><h3 id="s3dtitle">DsRNA stimulates IL-32 through COX-2 pathway during inflammatory response</h3><p id="__p28" class="p p-first">To define the role of COX-2 in the regulation of influenza A virus induced pro-inflammatory factor IL-32, poly(IC)&#x0002b;IFN-&#x003b3; treatment was used to mimic the influenza A virus infection in following experiments as reported previously<a href="#pone.0001985-LeGoffic1" rid="pone.0001985-LeGoffic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877987">[30]</a>.</p><p id="__p29">First, the effects of COX-2 on the activation of IL-32 promoter were determined. A549 cells were cotransfected with the reporter plasmid pIL-32-Luc and pcDNA3.1, pcDNA3.1-COX-2 plus different concentration of NS398 as mentioned in <a href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003" co-legend-rid="lgnd_pone-0001985-g003"><span>Fig. 3A</span></a>, pcDNA3.1 was used as empty vector control. Results from Luciferase activity assay showed that the level of IL-32 promoter activity was increased by COX-2 over-expression and it was blocked by COX-2 inhibitor NS398 in a dose-dependent manner.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001985-g003" co-legend-rid="lgnd_pone-0001985-g003"><a href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321469784640" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2288676_pone.0001985.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001985.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2288676/bin/pone.0001985.g003.jpg" /></a></div><div id="largeobj_idm140321469784640" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001985-g003"><div><a class="figpopup" href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>DsRNA induces IL-32 is in COX-2-dependent manner.</strong><p id="__p30">Reporter plasmid pIL-32-Luc (A), and pRL-TK were cotransfected along with pcDNA3.1-COX-2 or pcDNA3.1 into A549 cells. Transfected cells by COX-2 plasmids were incubated for 12 h and then maintained for 36 h with different final concentrations of NS398 as indicated, respectively. Luciferase activity was measured. Results are expressed as the mean&#x000b1;s.d. of three independent experiments performed in triplicate and normalized by Renilla activities. A549 cells were transfected with different indicated amounts of pcDNA3.1-COX-2 or pcDNA3.1. RT-PCR for IL-32 and &#x003b2;-actin (internal control) (B) in cell lysates, Elisa for IL-32 (C) in culture supernatants were performed. (D) A549 cells were treated with poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) for 12 h and then different concentration of NS398 was added as indicated for another 36 h. IL-32 and &#x003b2;-actin mRNA level were examined by RT-PCR. (E) A549 cells were stimulated by poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) with or without 80 &#x000b5;M NS398 for 48 h. Time-dependent of IL-32 expression in culture supernatants were measured. The data represent mean&#x000b1;s.d. of three separate experiments.</p></div></div></div><p id="__p31">Secondly, to determine the effects of COX-2 on the activation of IL-32 mRNA level and protein expression, A549 cells were transfected with different amounts of pcDNA3.1-COX-2. Results from RT-PCR using IL-32-specific, or &#x003b2;-actin-specific primers showed that the levels of IL-32 mRNA were increased as the amount of pcDNA3.1-COX-2 increased, but the levels of &#x003b2;-actin mRNA remained relatively constant (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003" co-legend-rid="lgnd_pone-0001985-g003"><span>Fig. 3B</span></a>). Furthermore, IL-32 production in culture supernatants was stimulated by COX-2 over-expression in a dose-dependent manner (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003" co-legend-rid="lgnd_pone-0001985-g003"><span>Fig. 3C</span></a>).</p><p id="__p32">Thirdly, results from RT-PCR analyses showed that the level of IL-32 mRNA activated by poly(IC)&#x0002b;IFN-&#x003b3; was suppressed by COX-2-specific inhibitor NS398 in a dose dependent manner (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003" co-legend-rid="lgnd_pone-0001985-g003"><span>Fig. 3D</span></a>). Furthermore, IL-32 accumulation in culture supernatants stimulated by poly(IC)&#x0002b;IFN-&#x003b3; were suppressed by 80 &#x000b5;M NS398 (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g003" rid-ob="ob-pone-0001985-g003" co-legend-rid="lgnd_pone-0001985-g003"><span>Fig. 3E</span></a>).</p><p id="__p33" class="p p-last">Taken together, these data suggest that COX-2 is an upstream regulatory factor of dsRNA-triggered IL-32 production.</p></div><div id="s3e" class="sec"><h3 id="s3etitle">IL-32 feedback inhibits dsRNA-induced COX-2 expression</h3><p id="__p34" class="p p-first">The effect of IL-32 on the regulation of COX-2 promoter was determined. A549 cells were cotransfected with the reporter plasmid pCOX-2-Luc and pCMV-Flag2A, Flag2A-IL-32. Results from Luciferase activity assay showed that the level of COX-2 promoter activity was decreased by IL-32 over-expression (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004" co-legend-rid="lgnd_pone-0001985-g004"><span>Fig. 4A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001985-g004" co-legend-rid="lgnd_pone-0001985-g004"><a href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321502092752" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2288676_pone.0001985.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001985.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2288676/bin/pone.0001985.g004.jpg" /></a></div><div id="largeobj_idm140321502092752" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001985-g004"><div><a class="figpopup" href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>The feedback inhibition of IL-32 to dsRNA-induced COX-2 expression.</strong><p id="__p35">Reporter plasmid pCOX-2-Luc (A) and pRL-TK were cotransfected along with Flag2A-IL-32 or control vectors (Flag2A) into A549 cells. Luciferase activity was then measured 48 h post transfection. A549 cells were transfected with different amounts of Flag2A-IL-32 as indicated or Flag2A and stimulated by poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) for 48 h. RT-PCR for COX-2 and &#x003b2;-actin (B) in lysated cells, measurement of PGE<sub>2</sub> release (C) in culture supernatants were taken. Reporter plasmid pCOX-2-Luc (D) and pRL-TK were cotransfected along with siRNA-IL-32 or siRNA-control into A549 cells and treated with poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) for 48 h. Luciferase activity was then measured. (E) A549 cells were transfected with siRNA-IL-32 or siRNA-control and stimulated by poly(IC) (50 &#x000b5;g/ml)&#x0002b;IFN-&#x003b3; (150 U/ml) for 48 h. Time-dependent PGE<sub>2</sub> release in culture supernatants was measured. The data represent mean&#x000b1;s.d. of three separate experiments.</p></div></div></div><p id="__p36">To determine the effects of IL-32 on the regulation of COX-2 mRNA expression, PGE<sub>2</sub> production, A549 cells were transfected with different amounts of Flag2A-IL-32 and treated with poly(IC)&#x0002b;IFN-&#x003b3; as the inducer. Results from RT-PCR using COX-2-specific, or &#x003b2;-actin-specific primers showed that the levels of COX-2 mRNA was decreased as the amount of Flag2A-IL-32 increased, but the levels of &#x003b2;-actin mRNA remained relatively constant (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004" co-legend-rid="lgnd_pone-0001985-g004"><span>Fig. 4B</span></a>). Furthermore, PGE<sub>2</sub> production in culture supernatants was suppressed by IL-32 over-expression in a dose-dependent manner (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004" co-legend-rid="lgnd_pone-0001985-g004"><span>Fig. 4C</span></a>).</p><p id="__p37">To confirm the above results, IL-32-specific siRNA was cotransfected along with reporter plasmid pCOX-2-Luc into A549 cells and treated with poly(IC)&#x0002b;IFN-&#x003b3;. Results from Luciferase activity assay showed that the level of COX-2 promoter activity was increased by knocking down IL-32 (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004" co-legend-rid="lgnd_pone-0001985-g004"><span>Fig. 4D</span></a>). Furthermore, PGE<sub>2</sub> production in culture supernatants stimulated with poly(IC)&#x0002b;IFN-&#x003b3; was enhanced by knocking down IL-32 (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g004" rid-ob="ob-pone-0001985-g004" co-legend-rid="lgnd_pone-0001985-g004"><span>Fig. 4E</span></a>).</p><p id="__p38" class="p p-last">Taken together, these data suggest that IL-32 plays a very important role in the inflammatory response following an influenza A/COX-2/IL-32 dependent positive regulatory order, while a negative feedback to COX-2 biosynthesis was also first observed.</p></div><div id="s3f" class="sec"><h3 id="s3ftitle">Influenza A-induced PGE<sub>2</sub> production and IL-32 expression were inhibited by NS398 and Aspirin</h3><p id="__p39" class="p p-first">To confirm the COX-2 and IL-32 regulatory loop, A549 cells were infected by influenza A virus and treated with or without selective COX-2 inhibitor NS398, or non-selective COX inhibitor Aspirin, a widely used anti-inflammatory drug. Results showed that IV-triggered PGE<sub>2</sub> release (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g005" rid-ob="ob-pone-0001985-g005" co-legend-rid="lgnd_pone-0001985-g005"><span>Fig. 5A</span></a>) and IL-32 (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g005" rid-ob="ob-pone-0001985-g005" co-legend-rid="lgnd_pone-0001985-g005"><span>Fig. 5B</span></a>) production in the culture supernatants were inhibited by either NS398 or Aspirin, which indicated that IL-32 is an important pro-inflammatory factor downstream of COX-2 during influenza A virus infection.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001985-g005" co-legend-rid="lgnd_pone-0001985-g005"><a href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/" target="figure" rid-figpopup="pone-0001985-g005" rid-ob="ob-pone-0001985-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321470530912" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2288676_pone.0001985.g005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001985.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2288676/bin/pone.0001985.g005.jpg" /></a></div><div id="largeobj_idm140321470530912" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001985-g005"><div><a class="figpopup" href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/" target="figure" rid-figpopup="pone-0001985-g005" rid-ob="ob-pone-0001985-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Selective COX-2 inhibitor NS398 suppresses IL-32 expression and IL-32-specific siRNA upregulates COX-2 in influenza A virus infected A549 cell.</strong><p id="__p40">A549 cells were infected by influenza A virus (1 MOI) and treated with or without 80 &#x000b5;M NS398, 5 mM Aspirin for 48 h as indicated on the horizontal axis. PGE<sub>2</sub> release (A) and IL-32 production (B) in culture supernatants were measured. A549 cells were transfected with siRNA-IL-32 or siRNA-control and infected by influenza A virus (1 MOI) for 48 h. PGE<sub>2</sub> release (C) and IL-32 production (D) in culture supernatants were measured. The data represent mean&#x000b1;s.d. of three separate experiments.</p></div></div></div></div><div id="s3g" class="sec sec-last"><h3 id="s3gtitle">Influenza A-induced PGE<sub>2</sub> production was increased by knocking down IL-32</h3><p id="__p41" class="p p-first">The effect of IL-32 on the regulation of IV infection induced PGE<sub>2</sub> production was also determined. We found that PGE<sub>2</sub> release in A549 cell culture supernatants stimulated by IV infection was increased (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g005" rid-ob="ob-pone-0001985-g005" co-legend-rid="lgnd_pone-0001985-g005"><span>Fig. 5C</span></a>) and IL-32 production decreased (<a href="/pmc/articles/PMC2288676/figure/pone-0001985-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g005" rid-ob="ob-pone-0001985-g005" co-legend-rid="lgnd_pone-0001985-g005"><span>Fig. 5D</span></a>) by knocking down IL-32.</p><p id="__p42" class="p">Taken together, these data demonstrate that a novel inflammatory pathway in response to influenza A virus infection and dsRNA treatment was identified as described in <a href="/pmc/articles/PMC2288676/figure/pone-0001985-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g006" rid-ob="ob-pone-0001985-g006" co-legend-rid="lgnd_pone-0001985-g006"><span>Fig. 6</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001985-g006" co-legend-rid="lgnd_pone-0001985-g006"><a href="/pmc/articles/PMC2288676/figure/pone-0001985-g006/" target="figure" rid-figpopup="pone-0001985-g006" rid-ob="ob-pone-0001985-g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321500383136" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2288676_pone.0001985.g006.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001985.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2288676/bin/pone.0001985.g006.jpg" /></a></div><div id="largeobj_idm140321500383136" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2288676/figure/pone-0001985-g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001985-g006"><div><a class="figpopup" href="/pmc/articles/PMC2288676/figure/pone-0001985-g006/" target="figure" rid-figpopup="pone-0001985-g006" rid-ob="ob-pone-0001985-g006">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>A model for regulation of pro-inflammatory factors COX-2 and IL-32 expression in response to influenza A virus infection and double-stranded RNA</strong></div></div></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p id="__p43" class="p p-first">Our results demonstrate that significant increase of serum COX-2-derived PGE<sub>2</sub> and IL-32 levels were observed in influenza A infected patients compared with healthy individuals. Viral infection resulted in 2.7-fold increase in PGE<sub>2</sub> synthesis and 58.2&#x00025; increase in IL-32 production. Both influenza A virus infection and poly(IC)&#x0002b;IFN-&#x003b3; treatment in A549 human lung epithelial cells were able to induce COX-2/ IL-32 mRNA and protein expression as well as PGE<sub>2</sub> and IL-32 accumulation in the cell culture supernatants. IL-32 was induced by influenza virus infection through COX-2-dependent mechanism.</p><p id="__p44">Although pro-inflammatory factor COX-2 has been identified as an obligatory mediator in the airway inflammation during influenza virus infection <a href="#pone.0001985-Mizumura1" rid="pone.0001985-Mizumura1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877966">[26]</a>, virtually little is currently known regarding the regulation of a newly identified proinfammatory factor IL-32 in influenza A virus infection or the mechanism whereby influenza A virus upregulates IL-32 expression. The present study provides considerable new information relevant to these issues. We identified first a COX-2/IL-32 regulatory loop in which COX-2 upregulated IL-32 expression and IL-32 feedback inhibited COX-2 expression in influenza A virus infected A549 lung epithelial cells. At present, a possible &#x0201c;cross-talk&#x0201d; between two important pro-inflammatory factors nitric oxide synthase (NOS) and COX has been extensively examined in different cell lines, tissues and under different pathophysiological conditions with conflicting results <a href="#pone.0001985-Goodwin1" rid="pone.0001985-Goodwin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665878001">[31]</a>. But the relationship between COX-2 and IL-32 has not been evaluated.</p><p id="__p45">Comparing the IV infection induced IL-32 level in cell culture with that in human individuals, a significant difference between them was observed, over 10-fold increase in cell culture versus 58.2&#x00025; in human individuals. It is likely the pro-inflammatory factor is not able to be increased sharply under physiological conditions due to complex inflammation network in which pro-inflammatory factors regulate each other.</p><p id="__p46">Two viral components, the NS1 and viral replicative intermediate dsRNA were identified to be involved in IV infection triggered COX-2 and IL-32 expression in A549 cells. Because TLR3 contributes directly to the inflammatory response of respiratory epithelial cells to both influenza A virus and dsRNA, we focused on the function of dsRNA in the regulation of COX-2 and IL-32 expression in this study. Role of viral NS1 protein in the pro-inflammatory process need further investigation.</p><p id="__p47">Cyclooxygenase metabolizes arachidonic acid to prostaglandins (PGs) and thromboxane <a href="#pone.0001985-Samuelsson1" rid="pone.0001985-Samuelsson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877998">[32]</a>. COX-2 has been elucidated to be crucial to the inflammatory response <a href="#pone.0001985-Vane1" rid="pone.0001985-Vane1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877986">[33]</a> and tumorigenesis <a href="#pone.0001985-Subbaramaiah1" rid="pone.0001985-Subbaramaiah1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877990">[34]</a>, <a href="#pone.0001985-Kutchera1" rid="pone.0001985-Kutchera1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877992">[35]</a>, so nonsteroidal anti-inflammatory drugs (NSAIDs) selective for its inhibition are used clinically to treat inflammatory arthropathies but always cause many side effects such as gastrointestinal (GI) mucosa damage and cardiovascular adverse events <a href="#pone.0001985-White1" rid="pone.0001985-White1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877968">[36]</a>, <a href="#pone.0001985-Naesdal1" rid="pone.0001985-Naesdal1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877984">[37]</a>, <a href="#pone.0001985-Coruzzi1" rid="pone.0001985-Coruzzi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877979">[38]</a>. Aspirin is one of the classic NSAIDs, and its anti-inflammatory activity is associated with cyclooxygenase inhibition directly or indirectly <a href="#pone.0001985-Wu1" rid="pone.0001985-Wu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877981">[39]</a>. NSAID-associated GI mucosal injury is an important clinical problem and the increased knowledge of physiological roles of COX-2 enzyme in a variety of tissues, including stomach and kidney, together with the withdrawal from the clinic trials of rofecoxib and valdecoxib because of cardiovascular toxicity, have challenged the benefits of selective COX-2 inhibition <a href="#pone.0001985-Coruzzi1" rid="pone.0001985-Coruzzi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665877999">[38]</a>. Our study identified a novel COX-2 downstream pro-inflammatory factor IL-32 which could be a potential target for screening anti-inflammatory drugs with less adverse effects.</p><p id="__p48" class="p p-last">In summary, these studies provide new insights into a novel model as described in <a href="/pmc/articles/PMC2288676/figure/pone-0001985-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001985-g006" rid-ob="ob-pone-0001985-g006" co-legend-rid="lgnd_pone-0001985-g006"><span>Fig. 6</span></a> in which influenza A virus or poly(IC)&#x0002b;IFN-&#x003b3; triggers pro-inflammatory factors COX-2 and IL-32 expression, COX-2-derived PGE<sub>2</sub> production, and subsequent host inflammatory responses. In this model, we further demonstrate that COX-2 is located up-stream of IL-32 in the positive regulatory pathway. The cross-talk between the two genes is described as follows: COX-2 upregulates IL-32 production, and conversely, IL-32 attenuates COX-2 activity.</p></div><div id="idm140321571487216" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321571487216title">Acknowledgments</h2><div class="sec"><p id="__p49">We thank Hubei provincial Center for Disease Control and Prevention (Hubei CDC) for providing serum samples with seronegative for influenza A antigen in this study, and thank Dr. Kenneth K. Wu for kindly providing plasmid pcDNA3.1-COX-2.</p></div></div><div id="idm140321571486336" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321571486336title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140321571486208"><p id="__p50" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm140321500441216"><p id="__p51" class="p p-first-last"><strong>Funding: </strong>This work was supported by research grants from the National Natural Science Foundation of China (No. 30570066), the Major State Basic Research Development Program of China (&#x0201c;973&#x0201d; project No. 2007CB512803 and No. 2005CB523010), the National High-Tech Research and Development Program of China (&#x0201c;863&#x0201d; project No. 2006AA02A306), Hubei Provincial Science Foundation for Distinguished Youth Scholar to Zhu Y, and the Ph.D. Program Foundation of Ministry of Education of China (No. 20050486012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></p></div></div><div id="idm140321500439424" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321500439424title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0001985-Heitmeier1">1. <span class="element-citation">Heitmeier MR, Scarim AL, Corbett JA. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:15301\xe2\x80\x9315307.</span> [<a href="/pubmed/9614147" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Double-stranded+RNA-induced+inducible+nitric-oxide+synthase+expression+and+interleukin-1+release+by+murine+macrophages+requires+NF-kappaB+activation.&amp;author=MR+Heitmeier&amp;author=AL+Scarim&amp;author=JA+Corbett&amp;volume=273&amp;publication_year=1998&amp;pages=15301-15307&amp;pmid=9614147&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Jacobs1">2. <span class="element-citation">Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. <span><span class="ref-journal">Virology. </span>1996;<span class="ref-vol">219</span>:339\xe2\x80\x93349.</span> [<a href="/pubmed/8638399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=When+two+strands+are+better+than+one:+the+mediators+and+modulators+of+the+cellular+responses+to+double-stranded+RNA.&amp;author=BL+Jacobs&amp;author=JO+Langland&amp;volume=219&amp;publication_year=1996&amp;pages=339-349&amp;pmid=8638399&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Guillot1">3. <span class="element-citation">Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, et al.  Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:5571\xe2\x80\x935580.</span> [<a href="/pubmed/15579900" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Involvement+of+toll-like+receptor+3+in+the+immune+response+of+lung+epithelial+cells+to+double-stranded+RNA+and+influenza+A+virus.&amp;author=L+Guillot&amp;author=R+Le+Goffic&amp;author=S+Bloch&amp;author=N+Escriou&amp;author=S+Akira&amp;volume=280&amp;publication_year=2005&amp;pages=5571-5580&amp;pmid=15579900&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Ciencewicki1">4. <span class="element-citation">Ciencewicki J, Brighton L, Wu WD, Madden M, Jaspers I. Diesel exhaust enhances virus- and poly(I:C)-induced Toll-like receptor 3 expression and signaling in respiratory epithelial cells. <span><span class="ref-journal">Am J Physiol Lung Cell Mol Physiol. </span>2006;<span class="ref-vol">290</span>:L1154\xe2\x80\x931163.</span> [<a href="/pubmed/16399790" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Lung+Cell+Mol+Physiol&amp;title=Diesel+exhaust+enhances+virus-+and+poly(I:C)-induced+Toll-like+receptor+3+expression+and+signaling+in+respiratory+epithelial+cells.&amp;author=J+Ciencewicki&amp;author=L+Brighton&amp;author=WD+Wu&amp;author=M+Madden&amp;author=I+Jaspers&amp;volume=290&amp;publication_year=2006&amp;pages=L1154-1163&amp;pmid=16399790&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Steer1">5. <span class="element-citation">Steer SA, Moran JM, Christmann BS, Maggi LB, Jr, Corbett JA. Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">177</span>:3413\xe2\x80\x933420.</span> [<a href="/pubmed/16920983" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Role+of+MAPK+in+the+regulation+of+double-stranded+RNA-+and+encephalomyocarditis+virus-induced+cyclooxygenase-2+expression+by+macrophages.&amp;author=SA+Steer&amp;author=JM+Moran&amp;author=BS+Christmann&amp;author=LB+Maggi&amp;author=JA+Corbett&amp;volume=177&amp;publication_year=2006&amp;pages=3413-3420&amp;pmid=16920983&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Steer2">6. <span class="element-citation">Steer SA, Moran JM, Maggi LB, Jr, Buller RM, Perlman H, et al.  Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. <span><span class="ref-journal">J Immunol. </span>2003;<span class="ref-vol">170</span>:1070\xe2\x80\x931076.</span> [<a href="/pubmed/12517975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Regulation+of+cyclooxygenase-2+expression+by+macrophages+in+response+to+double-stranded+RNA+and+viral+infection.&amp;author=SA+Steer&amp;author=JM+Moran&amp;author=LB+Maggi&amp;author=RM+Buller&amp;author=H+Perlman&amp;volume=170&amp;publication_year=2003&amp;pages=1070-1076&amp;pmid=12517975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Traynor1">7. <span class="element-citation">Traynor TR, Majde JA, Bohnet SG, Krueger JM. Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. <span><span class="ref-journal">Life Sci. </span>2004;<span class="ref-vol">74</span>:2563\xe2\x80\x932576.</span> [<a href="/pubmed/15010266" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;title=Intratracheal+double-stranded+RNA+plus+interferon-gamma:+a+model+for+analysis+of+the+acute+phase+response+to+respiratory+viral+infections.&amp;author=TR+Traynor&amp;author=JA+Majde&amp;author=SG+Bohnet&amp;author=JM+Krueger&amp;volume=74&amp;publication_year=2004&amp;pages=2563-2576&amp;pmid=15010266&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Eliopoulos1">8. <span class="element-citation">Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:16085\xe2\x80\x9316096.</span> [<a href="/pubmed/10347160" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Activation+of+the+p38+mitogen-activated+protein+kinase+pathway+by+Epstein-Barr+virus-encoded+latent+membrane+protein+1+coregulates+interleukin-6+and+interleukin-8+production.&amp;author=AG+Eliopoulos&amp;author=NJ+Gallagher&amp;author=SM+Blake&amp;author=CW+Dawson&amp;author=LS+Young&amp;volume=274&amp;publication_year=1999&amp;pages=16085-16096&amp;pmid=10347160&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Maggi1">9. <span class="element-citation">Maggi LB, Jr, Heitmeier MR, Scheuner D, Kaufman RJ, Buller RM, et al.  Potential role of PKR in double-stranded RNA-induced macrophage activation. <span><span class="ref-journal">EMBO J. </span>2000;<span class="ref-vol">19</span>:3630\xe2\x80\x933638.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC313973/">PMC free article</a>]</span> [<a href="/pubmed/10899117" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Potential+role+of+PKR+in+double-stranded+RNA-induced+macrophage+activation.&amp;author=LB+Maggi&amp;author=MR+Heitmeier&amp;author=D+Scheuner&amp;author=RJ+Kaufman&amp;author=RM+Buller&amp;volume=19&amp;publication_year=2000&amp;pages=3630-3638&amp;pmid=10899117&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Nath1">10. <span class="element-citation">Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:17098\xe2\x80\x9317102.</span> [<a href="/pubmed/10358063" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Transient+exposure+to+HIV-1+Tat+protein+results+in+cytokine+production+in+macrophages+and+astrocytes.+A+hit+and+run+phenomenon.&amp;author=A+Nath&amp;author=K+Conant&amp;author=P+Chen&amp;author=C+Scott&amp;author=EO+Major&amp;volume=274&amp;publication_year=1999&amp;pages=17098-17102&amp;pmid=10358063&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Hinz1">11. <span class="element-citation">Hinz B, Brune K. Cyclooxygenase-2&#x02013;10 years later. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2002;<span class="ref-vol">300</span>:367\xe2\x80\x93375.</span> [<a href="/pubmed/11805193" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Cyclooxygenase-2&#x02013;10+years+later.&amp;author=B+Hinz&amp;author=K+Brune&amp;volume=300&amp;publication_year=2002&amp;pages=367-375&amp;pmid=11805193&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Marnett1">12. <span class="element-citation">Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:22903\xe2\x80\x9322906.</span> [<a href="/pubmed/10438452" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Arachidonic+acid+oxygenation+by+COX-1+and+COX-2.+Mechanisms+of+catalysis+and+inhibition.&amp;author=LJ+Marnett&amp;author=SW+Rowlinson&amp;author=DC+Goodwin&amp;author=AS+Kalgutkar&amp;author=CA+Lanzo&amp;volume=274&amp;publication_year=1999&amp;pages=22903-22906&amp;pmid=10438452&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Deng1">13. <span class="element-citation">Deng WG, Zhu Y, Wu KK. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:4770\xe2\x80\x934777.</span> [<a href="/pubmed/12471036" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Up-regulation+of+p300+binding+and+p50+acetylation+in+tumor+necrosis+factor-alpha-induced+cyclooxygenase-2+promoter+activation.&amp;author=WG+Deng&amp;author=Y+Zhu&amp;author=KK+Wu&amp;volume=278&amp;publication_year=2003&amp;pages=4770-4777&amp;pmid=12471036&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Iniguez1">14. <span class="element-citation">Iniguez MA, Martinez-Martinez S, Punzon C, Redondo JM, Fresno M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:23627\xe2\x80\x9323635.</span> [<a href="/pubmed/10816557" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=An+essential+role+of+the+nuclear+factor+of+activated+T+cells+in+the+regulation+of+the+expression+of+the+cyclooxygenase-2+gene+in+human+T+lymphocytes.&amp;author=MA+Iniguez&amp;author=S+Martinez-Martinez&amp;author=C+Punzon&amp;author=JM+Redondo&amp;author=M+Fresno&amp;volume=275&amp;publication_year=2000&amp;pages=23627-23635&amp;pmid=10816557&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Liu1">15. <span class="element-citation">Liu M, Yang Y, Gu C, Yue Y, Wu KK, et al.  Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways. <span><span class="ref-journal">FASEB J. </span>2007;<span class="ref-vol">21</span>:1586\xe2\x80\x931596.</span> [<a href="/pubmed/17267381" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;title=Spike+protein+of+SARS-CoV+stimulates+cyclooxygenase-2+expression+via+both+calcium-dependent+and+calcium-independent+protein+kinase+C+pathways.&amp;author=M+Liu&amp;author=Y+Yang&amp;author=C+Gu&amp;author=Y+Yue&amp;author=KK+Wu&amp;volume=21&amp;publication_year=2007&amp;pages=1586-1596&amp;pmid=17267381&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Yan1">16. <span class="element-citation">Yan X, Hao Q, Mu Y, Timani KA, Ye L, et al.  Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. <span><span class="ref-journal">Int J Biochem Cell Biol. </span>2006;<span class="ref-vol">38</span>:1417\xe2\x80\x931428.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7108415/">PMC free article</a>]</span> [<a href="/pubmed/16546436" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biochem+Cell+Biol&amp;title=Nucleocapsid+protein+of+SARS-CoV+activates+the+expression+of+cyclooxygenase-2+by+binding+directly+to+regulatory+elements+for+nuclear+factor-kappa+B+and+CCAAT/enhancer+binding+protein.&amp;author=X+Yan&amp;author=Q+Hao&amp;author=Y+Mu&amp;author=KA+Timani&amp;author=L+Ye&amp;volume=38&amp;publication_year=2006&amp;pages=1417-1428&amp;pmid=16546436&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Carey1">17. <span class="element-citation">Carey MA, Bradbury JA, Seubert JM, Langenbach R, Zeldin DC, et al.  Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">175</span>:6878\xe2\x80\x936884.</span> [<a href="/pubmed/16272346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Contrasting+effects+of+cyclooxygenase-1+(COX-1)+and+COX-2+deficiency+on+the+host+response+to+influenza+A+viral+infection.&amp;author=MA+Carey&amp;author=JA+Bradbury&amp;author=JM+Seubert&amp;author=R+Langenbach&amp;author=DC+Zeldin&amp;volume=175&amp;publication_year=2005&amp;pages=6878-6884&amp;pmid=16272346&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Gilroy1">18. <span class="element-citation">Gilroy DW, Saunders MA, Wu KK. COX-2 expression and cell cycle progression in human fibroblasts. <span><span class="ref-journal">Am J Physiol Cell Physiol. </span>2001;<span class="ref-vol">281</span>:C188\xe2\x80\x93194.</span> [<a href="/pubmed/11401841" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Cell+Physiol&amp;title=COX-2+expression+and+cell+cycle+progression+in+human+fibroblasts.&amp;author=DW+Gilroy&amp;author=MA+Saunders&amp;author=KK+Wu&amp;volume=281&amp;publication_year=2001&amp;pages=C188-194&amp;pmid=11401841&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Kim1">19. <span class="element-citation">Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. <span><span class="ref-journal">Immunity. </span>2005;<span class="ref-vol">22</span>:131\xe2\x80\x93142.</span> [<a href="/pubmed/15664165" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Interleukin-32:+a+cytokine+and+inducer+of+TNFalpha.&amp;author=SH+Kim&amp;author=SY+Han&amp;author=T+Azam&amp;author=DY+Yoon&amp;author=CA+Dinarello&amp;volume=22&amp;publication_year=2005&amp;pages=131-142&amp;pmid=15664165&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Kundu1">20. <span class="element-citation">Kundu M, Basu J. IL-32: an emerging player in the immune response network against tuberculosis? <span><span class="ref-journal">PLoS Med. </span>2006;<span class="ref-vol">3</span>:e274.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1502156/">PMC free article</a>]</span> [<a href="/pubmed/16903776" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=IL-32:+an+emerging+player+in+the+immune+response+network+against+tuberculosis?&amp;author=M+Kundu&amp;author=J+Basu&amp;volume=3&amp;publication_year=2006&amp;pages=e274&amp;pmid=16903776&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Joosten1">21. <span class="element-citation">Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, et al.  IL-32, a proinflammatory cytokine in rheumatoid arthritis. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:3298\xe2\x80\x933303.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1413916/">PMC free article</a>]</span> [<a href="/pubmed/16492735" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=IL-32,+a+proinflammatory+cytokine+in+rheumatoid+arthritis.&amp;author=LA+Joosten&amp;author=MG+Netea&amp;author=SH+Kim&amp;author=DY+Yoon&amp;author=B+Oppers-Walgreen&amp;volume=103&amp;publication_year=2006&amp;pages=3298-3303&amp;pmid=16492735&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Netea1">22. <span class="element-citation">Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, et al.  Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. <span><span class="ref-journal">PLoS Med. </span>2006;<span class="ref-vol">3</span>:e277.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1539091/">PMC free article</a>]</span> [<a href="/pubmed/16903774" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=Mycobacterium+tuberculosis+induces+interleukin-32+production+through+a+caspase-+1/IL-18/interferon-gamma-dependent+mechanism.&amp;author=MG+Netea&amp;author=T+Azam&amp;author=EC+Lewis&amp;author=LA+Joosten&amp;author=M+Wang&amp;volume=3&amp;publication_year=2006&amp;pages=e277&amp;pmid=16903774&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Netea2">23. <span class="element-citation">Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, et al.  IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:16309\xe2\x80\x9316314.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1283464/">PMC free article</a>]</span> [<a href="/pubmed/16260731" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=IL-32+synergizes+with+nucleotide+oligomerization+domain+(NOD)+1+and+NOD2+ligands+for+IL-1beta+and+IL-6+production+through+a+caspase+1-dependent+mechanism.&amp;author=MG+Netea&amp;author=T+Azam&amp;author=G+Ferwerda&amp;author=SE+Girardin&amp;author=M+Walsh&amp;volume=102&amp;publication_year=2005&amp;pages=16309-16314&amp;pmid=16260731&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Novick1">24. <span class="element-citation">Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, et al.  Proteinase 3 is an IL-32 binding protein. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:3316\xe2\x80\x933321.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1413913/">PMC free article</a>]</span> [<a href="/pubmed/16488976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Proteinase+3+is+an+IL-32+binding+protein.&amp;author=D+Novick&amp;author=M+Rubinstein&amp;author=T+Azam&amp;author=A+Rabinkov&amp;author=CA+Dinarello&amp;volume=103&amp;publication_year=2006&amp;pages=3316-3321&amp;pmid=16488976&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-LaraPezzi1">25. <span class="element-citation">Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, et al.  The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. <span><span class="ref-journal">J Clin Invest. </span>2002;<span class="ref-vol">110</span>:1831\xe2\x80\x931838.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC151651/">PMC free article</a>]</span> [<a href="/pubmed/12488433" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=The+hepatitis+B+virus+X+protein+promotes+tumor+cell+invasion+by+inducing+membrane-type+matrix+metalloproteinase-1+and+cyclooxygenase-2+expression.&amp;author=E+Lara-Pezzi&amp;author=MV+Gomez-Gaviro&amp;author=BG+Galvez&amp;author=E+Mira&amp;author=MA+Iniguez&amp;volume=110&amp;publication_year=2002&amp;pages=1831-1838&amp;pmid=12488433&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Mizumura1">26. <span class="element-citation">Mizumura K, Hashimoto S, Maruoka S, Gon Y, Kitamura N, et al.  Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells. <span><span class="ref-journal">Clin Exp Allergy. </span>2003;<span class="ref-vol">33</span>:1244\xe2\x80\x931251.</span> [<a href="/pubmed/12956746" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Allergy&amp;title=Role+of+mitogen-activated+protein+kinases+in+influenza+virus+induction+of+prostaglandin+E2+from+arachidonic+acid+in+bronchial+epithelial+cells.&amp;author=K+Mizumura&amp;author=S+Hashimoto&amp;author=S+Maruoka&amp;author=Y+Gon&amp;author=N+Kitamura&amp;volume=33&amp;publication_year=2003&amp;pages=1244-1251&amp;pmid=12956746&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Zhu1">27. <span class="element-citation">Zhu Y, Saunders MA, Yeh H, Deng WG, Wu KK. Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:6923\xe2\x80\x936928.</span> [<a href="/pubmed/11741938" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Dynamic+regulation+of+cyclooxygenase-2+promoter+activity+by+isoforms+of+CCAAT/enhancer-binding+proteins.&amp;author=Y+Zhu&amp;author=MA+Saunders&amp;author=H+Yeh&amp;author=WG+Deng&amp;author=KK+Wu&amp;volume=277&amp;publication_year=2002&amp;pages=6923-6928&amp;pmid=11741938&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Shoda1">28. <span class="element-citation">Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, et al.  Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. <span><span class="ref-journal">Arthritis Res Ther. </span>2006;<span class="ref-vol">8</span>:R166.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1794509/">PMC free article</a>]</span> [<a href="/pubmed/17078892" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Res+Ther&amp;title=Interactions+between+IL-32+and+tumor+necrosis+factor+alpha+contribute+to+the+exacerbation+of+immune-inflammatory+diseases.&amp;author=H+Shoda&amp;author=K+Fujio&amp;author=Y+Yamaguchi&amp;author=A+Okamoto&amp;author=T+Sawada&amp;volume=8&amp;publication_year=2006&amp;pages=R166&amp;pmid=17078892&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Copeland1">29. <span class="element-citation">Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, et al.  Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1994;<span class="ref-vol">91</span>:11202\xe2\x80\x9311206.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC45195/">PMC free article</a>]</span> [<a href="/pubmed/7972034" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Mechanism+of+selective+inhibition+of+the+inducible+isoform+of+prostaglandin+G/H+synthase.&amp;author=RA+Copeland&amp;author=JM+Williams&amp;author=J+Giannaras&amp;author=S+Nurnberg&amp;author=M+Covington&amp;volume=91&amp;publication_year=1994&amp;pages=11202-11206&amp;pmid=7972034&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-LeGoffic1">30. <span class="element-citation">Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, et al.  Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. <span><span class="ref-journal">J Immunol. </span>2007;<span class="ref-vol">178</span>:3368\xe2\x80\x933372.</span> [<a href="/pubmed/17339430" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Cutting+Edge:+Influenza+A+virus+activates+TLR3-dependent+inflammatory+and+RIG-I-dependent+antiviral+responses+in+human+lung+epithelial+cells.&amp;author=R+Le+Goffic&amp;author=J+Pothlichet&amp;author=D+Vitour&amp;author=T+Fujita&amp;author=E+Meurs&amp;volume=178&amp;publication_year=2007&amp;pages=3368-3372&amp;pmid=17339430&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Goodwin1">31. <span class="element-citation">Goodwin DC, Landino LM, Marnett LJ. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. <span><span class="ref-journal">FASEB J. </span>1999;<span class="ref-vol">13</span>:1121\xe2\x80\x931136.</span> [<a href="/pubmed/10385604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;title=Effects+of+nitric+oxide+and+nitric+oxide-derived+species+on+prostaglandin+endoperoxide+synthase+and+prostaglandin+biosynthesis.&amp;author=DC+Goodwin&amp;author=LM+Landino&amp;author=LJ+Marnett&amp;volume=13&amp;publication_year=1999&amp;pages=1121-1136&amp;pmid=10385604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Samuelsson1">32. <span class="element-citation">Samuelsson B. An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes. <span><span class="ref-journal">Drugs 33 Suppl. </span>1987;<span class="ref-vol">1</span>:2\xe2\x80\x939.</span> [<a href="/pubmed/3036460" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs+33+Suppl&amp;title=An+elucidation+of+the+arachidonic+acid+cascade.+Discovery+of+prostaglandins,+thromboxane+and+leukotrienes.&amp;author=B+Samuelsson&amp;volume=1&amp;publication_year=1987&amp;pages=2-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Vane1">33. <span class="element-citation">Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, et al.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1994;<span class="ref-vol">91</span>:2046\xe2\x80\x932050.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC43306/">PMC free article</a>]</span> [<a href="/pubmed/7510883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Inducible+isoforms+of+cyclooxygenase+and+nitric-oxide+synthase+in+inflammation.&amp;author=JR+Vane&amp;author=JA+Mitchell&amp;author=I+Appleton&amp;author=A+Tomlinson&amp;author=D+Bishop-Bailey&amp;volume=91&amp;publication_year=1994&amp;pages=2046-2050&amp;pmid=7510883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Subbaramaiah1">34. <span class="element-citation">Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, et al.  Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. <span><span class="ref-journal">Cancer Res. </span>1996;<span class="ref-vol">56</span>:4424\xe2\x80\x934429.</span> [<a href="/pubmed/8813136" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Transcription+of+cyclooxygenase-2+is+enhanced+in+transformed+mammary+epithelial+cells.&amp;author=K+Subbaramaiah&amp;author=N+Telang&amp;author=JT+Ramonetti&amp;author=R+Araki&amp;author=B+DeVito&amp;volume=56&amp;publication_year=1996&amp;pages=4424-4429&amp;pmid=8813136&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Kutchera1">35. <span class="element-citation">Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, et al.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1996;<span class="ref-vol">93</span>:4816\xe2\x80\x934820.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC39362/">PMC free article</a>]</span> [<a href="/pubmed/8643486" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Prostaglandin+H+synthase+2+is+expressed+abnormally+in+human+colon+cancer:+evidence+for+a+transcriptional+effect.&amp;author=W+Kutchera&amp;author=DA+Jones&amp;author=N+Matsunami&amp;author=J+Groden&amp;author=TM+McIntyre&amp;volume=93&amp;publication_year=1996&amp;pages=4816-4820&amp;pmid=8643486&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-White1">36. <span class="element-citation">White WB. Cardiovascular effects of the selective cyclooxygenase-2 inhibitors. <span><span class="ref-journal">Subcell Biochem. </span>2007;<span class="ref-vol">42</span>:145\xe2\x80\x93158.</span> [<a href="/pubmed/17612049" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Subcell+Biochem&amp;title=Cardiovascular+effects+of+the+selective+cyclooxygenase-2+inhibitors.&amp;author=WB+White&amp;volume=42&amp;publication_year=2007&amp;pages=145-158&amp;pmid=17612049&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Naesdal1">37. <span class="element-citation">Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options. <span><span class="ref-journal">Drug Saf. </span>2006;<span class="ref-vol">29</span>:119\xe2\x80\x93132.</span> [<a href="/pubmed/16454539" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Saf&amp;title=NSAID-associated+adverse+effects+and+acid+control+aids+to+prevent+them:+a+review+of+current+treatment+options.&amp;author=J+Naesdal&amp;author=K+Brown&amp;volume=29&amp;publication_year=2006&amp;pages=119-132&amp;pmid=16454539&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Coruzzi1">38. <span class="element-citation">Coruzzi G, Venturi N, Spaggiari S. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond. <span><span class="ref-journal">Acta Biomed. </span>2007;<span class="ref-vol">78</span>:96\xe2\x80\x93110.</span> [<a href="/pubmed/17933277" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Biomed&amp;title=Gastrointestinal+safety+of+novel+nonsteroidal+antiinflammatory+drugs:+selective+COX-2+inhibitors+and+beyond.&amp;author=G+Coruzzi&amp;author=N+Venturi&amp;author=S+Spaggiari&amp;volume=78&amp;publication_year=2007&amp;pages=96-110&amp;pmid=17933277&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001985-Wu1">39. <span class="element-citation">Wu KK. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. <span><span class="ref-journal">Semin Vasc Med. </span>2003;<span class="ref-vol">3</span>:107\xe2\x80\x93112.</span> [<a href="/pubmed/15199473" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Vasc+Med&amp;title=Aspirin+and+other+cyclooxygenase+inhibitors:+new+therapeutic+insights.&amp;author=KK+Wu&amp;volume=3&amp;publication_year=2003&amp;pages=107-112&amp;pmid=15199473&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2288676&amp;issue-id=162310&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2288676/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2288676/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2288676/pdf/pone.0001985.pdf">PDF (573K)</a></li> | <li><a href="#" data-citationid="PMC2288676" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2288676%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2288676%2F&amp;text=Activation%20of%20Interleukin-32%20Pro-Inflammatory%20Pathway%20in%20Response%20to%20Influenza%20A%20Virus%20Infection"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2288676%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18414668" data-aiid="2288676" data-aid="2288676" data-iid="162310" data-domainid="440" data-domain="plosone" data-accid="PMC2288676" data-md5="87516c3d4f0676d0f0106b910ce0794b"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:40:12-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BDCB5E99A96810000000005AC05AC&amp;ncbi_session=8A1BDCB5E99B1BC1_1452SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2288676%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2288676/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BDCB5E99B1BC1_1452SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'